1. Introduction 1.1 Bone morphogenetic proteins Bone morphogenetic proteins (BMPs) are family of growth factors. (Chen et al., 2004; Vukicevic & Sampath, 2008) Discovered in context of bone biology, today they are recognized as important signaling molecules in wide range of biological processes, such as vertebrate embryonic development (Hogan, 1996), mesenchymal stem cell differentiation (Vukicevic & Grgurevic, 2009), kidney fibrosis, and more. For the last years BMP-2 and BMP-7 are used as therapeutics in orthopedics, harnessing their regenerative potential as growth factors. From the onset of medicine scholars have been aware of the bone regenerative potential. In 1965. Urist was first to show that demineralized bone matrix (DBM) can induce bone growth if implanted into extraskeletal site. Active component from DBM was named bone morphogenetic protein by Urist & Strates (1971). Purification, cloning and sequencing of BMP was done almost 20 years later by Wozney et al. (1988). They showed that BMP is not a single protein but a family of growth factors. From introduction of the BMP term through cloning and sequencing of individual BMPs in late 1980s, scientific output in the field has constantly grown and has exceeded 1500 papers in 2010. (Figure 1) BMPs are part of transforming growth factor (TGF- ) superfamily of proteins. In humans TGF- superfamily constitutes of 37 proteins. (Figure 2) Beside BMPs, TGF- superfamily includes TGF- proteins, inhibins (INH), growth/differentiation factors (GDF) and few others: artemin (ARTN), glial cell line-derived neurotrophic factor (GDNF), left-right determination factor 1 (LFTY1), LFTY2, muellerian-inhibiting factor (MIS), nodal homolog (NODAL), neurturin (NRTN) and persephin (PSPN). BMPs are functionally and structurally very conserved throughout animal kingdom. Their biological importance is reflected through functional and structural redundancy of different BMPs in single species. BMPs are translated as pre-propeptides. Signal peptide targets them for secretion out of cell. Prodomain is two thirds to four fifths of total peptide length and The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples Genadij Razdorov and Slobodan Vukicevic Laboratory of Mineralized Tissues, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Zagreb Croatia 12 www.intechopen.com
28
Embed
The Use of Mass Spectrometry in Characterization of Bone ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1. Introduction
1.1 Bone morphogenetic proteins
Bone morphogenetic proteins (BMPs) are family of growth factors. (Chen et al., 2004;Vukicevic & Sampath, 2008) Discovered in context of bone biology, today they arerecognized as important signaling molecules in wide range of biological processes, suchas vertebrate embryonic development (Hogan, 1996), mesenchymal stem cell differentiation(Vukicevic & Grgurevic, 2009), kidney fibrosis, and more. For the last years BMP-2 and BMP-7are used as therapeutics in orthopedics, harnessing their regenerative potential as growthfactors.From the onset of medicine scholars have been aware of the bone regenerative potential.In 1965. Urist was first to show that demineralized bone matrix (DBM) can induce bonegrowth if implanted into extraskeletal site. Active component from DBM was named bonemorphogenetic protein by Urist & Strates (1971). Purification, cloning and sequencing of BMPwas done almost 20 years later by Wozney et al. (1988). They showed that BMP is not a singleprotein but a family of growth factors.From introduction of the BMP term through cloning and sequencing of individual BMPs in
late 1980s, scientific output in the field has constantly grown and has exceeded 1500 papers in2010. (Figure 1)BMPs are part of transforming growth factor (TGF- ) superfamily of proteins. In humansTGF- superfamily constitutes of 37 proteins. (Figure 2) Beside BMPs, TGF- superfamilyincludes TGF- proteins, inhibins (INH), growth/differentiation factors (GDF) and few others:artemin (ARTN), glial cell line-derived neurotrophic factor (GDNF), left-right determinationfactor 1 (LFTY1), LFTY2, muellerian-inhibiting factor (MIS), nodal homolog (NODAL),neurturin (NRTN) and persephin (PSPN).BMPs are functionally and structurally very conserved throughout animal kingdom. Theirbiological importance is reflected through functional and structural redundancy of differentBMPs in single species. BMPs are translated as pre-propeptides. Signal peptide targets themfor secretion out of cell. Prodomain is two thirds to four fifths of total peptide length and
The Use of Mass Spectrometry in Characterization of Bone Morphogenetic
Proteins from Biological Samples
Genadij Razdorov and Slobodan Vukicevic Laboratory of Mineralized Tissues, Center for Translational and Clinical Research,
School of Medicine, University of Zagreb, Zagreb Croatia
12
www.intechopen.com
2 Will-be-set-by-IN-TECH
Fig. 1. Scientific output on bone morphogenetic protein (solid black line), (mass spectrometry)protein OR proteomics (dashed black line) and (mass spectrometry) AND bone morphogeneticprotein (green bars). Data gathered from Pubmed on June 2011.
Fig. 2. Transforming growth factor protein superfamily. Amino acid sequences werealigned by ClustalW and plotted by Cytoscape with PhyloTree plugin.
is cleaved off to produce mature peptide chain. Mature domain is highly conserved andhas number of shared features. (Figure 3) There are seven conserved cysteines starting fromposition 446 (by unified position numbering displayed above aligned sequences), and then on
260 Tandem Mass Spectrometry – Applications and Principles
www.intechopen.com
The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples 3
positions 475, 479, 511, 512, 545 and 547. Counting from first conserved cysteine there are 30completely conserved positions which is almost one third length of mature domain.From purification and sequencing studies done in late 1980s, it was clear that the active formof a BMP is a homodimer made up of two mature domains connected by disulphide bridge.The first BMP crystal structure was resolved by Griffith et al. (1996). Until present there aremore then 30 structures related to BMPs deposited into Protein Data Bank.BMP mature domain is folded in the hand like structure. (Figure 4) Two fingers, made up oftwo beta sheets, are protruding from the cystine knot, which is made up of three disulphidebridges. On the opposite side of the cystine knot is alpha helix forming the heel of the hand.Active homodimer is made up of two hand structures pointing in the opposing directionspalms facing toward each other.
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
1
1
1
1
1
1
1
1
1
1
30
34
22
30
32
27
20
20
29
50
10 20 30 40
− − − − − − − − −M G S L V L T L C A L F C L A A Y L V S G S P IM N L E Q S − − − − − − − − − − −
− − − − − − −M C P G A L W V A L P L L S L L A G S L Q −G K P L Q S W G R G S A G − − − − − − − −
− − − − − − − − − −M H A H C L P F L L H A W W A L L Q A G A A − − − − − − − − − − − − − − − − − −
− − − − − − − − − −M V A G T R C L L A L L L P Q V L L G G A − − A G L V P E L G R − − − − − − − −C L L A L L L P Q V L L G G A A G L V P E L G RC L L A L L L P Q V L L G G A A G L V P E L G R
− − − − − − − − − −M IP G N R M L M V V L L C Q V L L G G A S H A S L IP E TG K − − − − − − − −
− − − − − − − − − −M H L T V F L L K G IV G F − − L W S C W V L V G Y A K G − − − − − − − − − − −
− − − − − − − − − − − − − − − − −M A A R P G P − − L W L L G L T L C A L G G − − − − − − − − − − −
− − − − − − − − − − − − − − − − −M T A L P G P − − L W L L G L A L C A L G G − − − − − − − − − − −
− − − − − − − − − −M H V R S L R A A A P H S F V A L W A P L F L L R S A L A − − − − − − − − − − −
M P G L G R R A Q W L C W W W G L L C S C C G P P P L R P P L P A A A A A A A G G Q L L G D G G S PM P G L G R
31
35
23
31
33
28
21
21
30
51
75
79
38
70
74
68
61
61
71
96
60 70 80 90
− − − − − P L E E D M S L F G D V F S E Q D G V D F N T L L Q S M K D E F L K T L N L S D IP TQ D
− − − −G N A H S P L G V P G G G L P E H T − F N L K M F L E N V K V D F L R S L N L S G V P S Q DS L N L S G V P S Q D
− − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − T V A T A L L R T R G Q P S S P − − −T R G Q P S S PG Q P S S P
− − − − R K F A A A S − − S G R P S S Q P S − − − −D E V L S E F E L R L L S M F G L K Q R P T P SRR K F A A A S S G RF A A A S S G R
− − − − K K V A E IQ G H A G G R R S G Q S − − − −H E L L R D F E A T L L Q M F G L R R R P Q P SV A E IQ G H A G G R D F E A T L L Q M F G L R
− − − −G L G −D N H V H S S F IY R R L R − − − −N H E R R E IQ R E IL S IL G L P H R P R P F
− − − − −G G P G L R P P P G C P Q R R L G − − − − A R E R R D V Q R E IL A V L G L P G R P R P RP P P G C P Q R R L G A R E IL A V L G L P G R P R
− − − − −G G P G L R P P P G C P Q R R L G − − − − A R E R R D V Q R E IL A V L G L P G R P R P R
− − − −D F S L D N E V H S S F IH R R L R − − − − S Q E R R E M Q R E IL S IL G L P H R P R P H
G R T E Q P P P S P Q S S S G F L Y R R L K − − − − TQ E K R E M Q K E IL S V L G L P H R P R P LP R P L
76
80
39
71
75
69
62
62
72
97
94
98
49
89
93
90
87
87
92
146
110 120 130 140
S A K − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − V D P P E Y M L E L Y N K F A T −V D P P E Y M L E L Y N K F A T
K T R − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − V E P P Q Y M ID L Y N R Y T S −K T R
− − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − S P L A Y M L S L Y R − − − − −S P L A Y M L S L Y RS P L A Y M L S L Y R
R D − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − A V V P P Y M L D L Y R R H S G Q
K S − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − A V IP D Y M R D L Y R L Q S G E
S − − − − − − − − − − − − − − − − − − − − − − − − − − − P G K Q A S S A P L F M L D L Y N A M TN −
A P − − − − − − − − − − − − − − − − − − − − − − − − P A A S R L P A S A P L F M L D L Y H A M A G D
A P − − − − − − − − − − − − − − − − − − − − − − − − P A A S R L P A S A P L F M L D L Y H A M A G DA P P A A S R L P A S A P L F M L D L Y H A M A G DL P A S A P L F M L D L Y H A M A G D
L − − − − − − − − − − − − − − − − − − − − − − − − − − −Q G K H N − S A P M F M L D L Y N A M A V −
H G L Q Q P Q P P A L R Q Q E E Q Q Q Q Q Q L P R G E P P P G R L K S A P L F M L D L Y N A L S A DH G L Q Q P Q P P A L R
− − E E N P E E S E Y S V R A S L A E E T R G A R K G Y P A S P N G Y P R R IQ L S R T T P L T TQG Y P A S P N G Y P RG Y P A S P N G Y P R R IQ L S R
D D E D G − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − −
D D E D G − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − − −D D E D GD D E D G
− − E E G − − − − − − − − − − − − − − − − −G G P G G Q G F S − − − Y P Y K A V F S − − − − − − TQ
N D E D G A S E G E R Q Q S W P H E A A S S S Q R R Q P P P G A A H P L N R K S L L A P G S G S G G
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
Fig. 3. BMPs sequence alignment. Ten most conserved BMPs aligned by ClustalW algorithmwith most conserved residues color coded by their physicochemical properties (Zappo colorscheme). Green sequence features are MS identified peptides deposited in PRIDE proteomicsdatabase.
261The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples
www.intechopen.com
4 Will-be-set-by-IN-TECH
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
95
99
50
95
99
139
93
93
115
197
135
140
83
140
148
188
136
136
164
246
210 220 230 240
− − − − − − − −D R T S M P S A N I IR S F K N E D L F S Q P V S F N G − L R K Y P L L F N V S IPD R T S M P S A N I IR S F K N E D L F S Q P V S F N G L R KN E D L F S Q P V S F N G L R
− − − − − − − −D K S T T P A S N IV R S F S M E D A IS I T A T E D F P F Q K H IL L F N IS IPS T T P A S N IV R
− − − − − − − − − −D P L P R A D I IR S L Q A E D V A V D − − − − − −G Q N W T F A F D F S F L S
P D H R − − − − L E R A A S R A N T V R S F H H E E S L E E L P E T S G K T T R R F F F N L S S IPA A S R A N T V R
IH S TG L E Y P E R P A S R A N T V R S F H H E E H L E N IP G T S E N S A F R F L F N L S S IP
S P P L A S L H D TN F L N D A D M V M S F V N L V E R D K D F S H Q R R H Y K E F R F D L TQ IP
− − − − − − A P A E Q R L G R A D L V M S F V N M V E R D R A L G H Q E P H W K E F R F D L TQ IPA D L V M S F V N M V E R D R
− − − − − − A P A E R R L G R A D L V M S F V N M V E R D R A L G H Q E P H W K E F R F D L TQ IPA P A E RA P A E R R A D L V M S F V N M V E R D RD R A L G H Q E P H W K
G P P L A S L Q D S H F L TD A D M V M S F V N L V E H D K E F F H P R Y H H R E F R F D L S K IPF D L S K IP
A S P L T S A Q D S A F L N D A D M V M S F V N L V E Y D K E F S P R Q R H H K E F K F N L S Q IP
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
136
141
84
141
149
189
137
137
165
247
183
189
126
189
197
232
179
179
208
290
260 270 280 290
H H E E V IM A E L R L Y T L V Q R D R M IY D G − V D R K I T IF E V L E − S K G D N E G E R N MK I T IF E V L E S K
R H E Q I T R A E L R L Y V S C Q N H V D P S H D − L K G S V V IY D V L D G TD A W D S A T E T K
Q Q E D L A W A E L R L Q L S S P V D L P T E G − − − S L A IE IF H Q P K P − − − −D T E Q A S D
T E E F I T S A E L Q V F R E Q M Q D A L G N N S S F H H R IN IY E I IK P − A T A N S K F P V TF P V T
E N E V IS S A E L R L F R E Q V D Q G P D W E R G F H − R IN IY E V M K P P A E V V P G H L I T
H G E A V T A A E F R IY K D R S N N R F E N − − − E T IK IS IY Q I IK E − − − Y TN R D A D LS N N R F E N E T IK IS IY Q I IK E Y TN R
A G E A V T A A E F R IY K − V P S IH L L N − − − R T L H V S M F Q V V Q E − − −Q S N R E S D LV P S IH L L N R
A G E A V T A A E F R IY K − V P S IH L L N − − − R T L H V S M F Q V V Q E − − −Q S N R E S D LV P S IH L L N R T L H V S M F Q V V Q E Q S N R E S D L
E G E A V T A A E F R IY K D Y IR E R F D N − − − E T F R IS V Y Q V L Q E − − −H L G R E S D LE G E A V T A A E F R E S D L
E G E V V T A A E F R IY K D C V M G S F K N − − −Q T F L IS IY Q V L Q E − − −H Q H R D S D L
184
190
127
190
198
233
180
180
209
291
231
236
172
237
245
280
227
227
256
338
310 320 330 340
L V L V S G E IY G TN S E W E T F D V TD A IR R W Q K S G S − − S TH Q L E V H IE S K H D E AW Q K S G S S TH Q L E V H IE S KS G S S TH Q L E V H IE S K H D E A
T F L V S Q D IQ − −D E G W E T L E V S S A V K R W V R S D S T K S K N K L E V T V E S −H R K GG
S C L E R F Q M D L F T V T L S Q V T F S L G S M V L E V T R P − − − − L S K W L K H P G A L E K Q
R L L D T R L V N Q N A S R W E S F D V T P A V M R W T A Q G H − − A N H G F V V E V A H L E E K QR L L D T R W T A Q G H A N H G F V V E V A H L E E K
R L L D T R L V H H N V T R W E T F D V S P A V L R W T R E K Q − − P N Y G L A IE V TH L H Q T R
F L L D T R K A Q A L D V G W L V F D I T V T S N H W V IN P Q − −N N L G L Q L C A E TG D G R S
F F L D L Q T L R A G D E G W L V L D V T A A S D C W L L K R H − − K D L G L R L Y V E T E D G H SA G D E G W L V L D V T A A S D C W L L K
F F L D L Q T L R A G D E G W L V L D V T A A S D C W L L K R H − − K D L G L R L Y V E T E D G H SF F L D L Q T L R A G D E G W L V L D V T A A S D C W L L K R
F L L D S R T L W A S E E G W L V F D I T A T S N H W V V N P R − −H N L G L Q L S V E T L D G Q SF L L D S R
F L L D T R V V W A S E E G W L E F D I T A T S N L W V V T P Q − −H N M G L Q L S V V T R D G V HD G V H
232
237
173
238
246
281
228
228
257
339
280
282
222
283
293
329
277
277
306
388
360 370 380 390
E D A S S G R L E ID T S A Q N K H N P L L IV F S D D Q S S −D K E R K E E L N E M IS H E Q L PE D A S S G R L E ID T S A Q N K H N P L L IV F S D D Q S S D K
C D T − − − − L D IS V P P G S R N L P F F V V F S N D H S S G T K E T R L E L R E M IS H E Q E SC D T L D IS V P P G S R N L P F F V V F S N D H S S G T KN L P F F V V F S N D H S S G T K E T R
M S R V A G E C W P R P P T P P A TN V L L M L Y S N L S Q E Q R Q L G G S T L L W E A E S S W R AA
G V S K R H V R IS R S L H Q D E H − − S W S Q IR P L L V T F G H D G K G H P L H K R − − E K R QH V R IS R
TH Q G Q H V R IS R S L P Q G S G − −N W A Q L R P L L V T F G H D G R G H A L T R R R R A K R S
IN V K S A G L V G R Q G P Q S K Q P F M V A F F K A S E V L L R S V R A A N − K R K N Q N R N K SN K S
V D P G L A G L L G Q R A P R S Q Q P F V V T F F R A S P S P IR T P R A V R P L R R R Q P K K S NS Q Q P F V V T F F R
V D P G L A G L L G Q R A P R S Q Q P F V V T F F R A S P S P IR T P R A V R P L R R R Q P K K S NS Q Q P F V V T F F R S N
IN P K L A G L IG R H G P Q N K Q P F M V A F F K A T E V H F R S IR S TG S K Q R S Q N R S K TQ P F M V A F F K A T E V H F R
V H P R A A G L V G R D G P Y D K Q P F M V A F F K V S E V H V R T T R S A S S R R R Q Q S R N R SV H P R A A G L V G RA A G L V G R D G P Y D K Q P F M V A F F K V S E V H V R
281
283
223
284
294
330
278
278
307
389
327
331
251
300
312
357
305
305
334
416
410 420 430 440
E L D N L G L D S F S S G P G E E A L L Q M R S N I IY D S T A R IR R N − − − A K G N Y C K R T P
V L K K L S K D G − S T E A G E S S H E E D TD G H V A A G S T L A R R K R S A G A G S H C Q K T SL S K D G S T E A G E S S H E E D TD G H V A A G S T L A R S A G A G S H C Q K
Q E G Q L S W E W G K R H R R H H L P D R S Q − − − − − − − − − − − − − − − − − − − − − L C R K V KQ E G Q L S W E W G K
A K H K − − − − − − − − − −Q R K R L K S − − − − − − − − − − − − − − − − − − − − − − − S C K R H P
P K H H S − − − − − − − − −Q R A R K K N K − − − − − − − − − − − − − − − − − − − − − −N C R R H S
S S H Q D S S R M S S V G D Y N T S E Q K Q − − − − − − − − − − − − − − − − − − − − − − A C K K H ES S H Q D S S R M S S V G D Y N T S E Q K
E L P Q A N R L P G IF D D V R G S H G R Q − − − − − − − − − − − − − − − − − − − − − − V C R R H E
E L P Q A N R L P G IF D D V H G S H G R Q − − − − − − − − − − − − − − − − − − − − − − V C R R H EE L P Q A N R L P G IF D D V H G S H G R Q V C R
P K N Q E A L R M A N V A E N S S S D Q R Q − − − − − − − − − − − − − − − − − − − − − − A C K K H EN Q E A L R M A N V A E N S S S D Q RM A N V A E N S S S D Q R
TQ S Q D V A R V S S A S D Y N S S E L K T − − − − − − − − − − − − − − − − − − − − − − A C R K H EK H E
328
332
252
301
313
358
306
306
335
417
377
381
301
350
362
407
355
355
384
466
460 470 480 490
L Y ID F K E IG W D S W I IA P P G Y E A Y E C R G V C N Y P L A E H L T P T K H A I IQ A L V H
L R V N F E D IG W D S W I IA P K E Y E A Y E C K G G C F F P L A D D V T P T K H A IV Q T L V H
F Q V D F N L IG W G S W I IY P K Q Y N A Y R C E G E C P N P V G E E F H P TN H A Y IQ S L L K
L Y V D F S D V G W N D W IV A P P G Y H A F Y C H G E C P F P L A D H L N S TN H A IV Q T L V N
L Y V D F S D V G W N D W IV A P P G Y Q A F Y C H G D C P F P L A D H L N S TN H A IV Q T L V N
L Y V S F R D L G W Q D W I IA P E G Y A A F Y C D G E C S F P L N A H M N A TN H A IV Q T L V H
L Y V S F Q D L G W L D W V IA P Q G Y S A Y Y C E G E C S F P L D S C M N A TN H A IL Q S L V HS L V H
L Y V S F Q D L G W L D W V IA P Q G Y S A Y Y C E G E C S F P L D S C M N A TN H A IL Q S L V H
L Y V S F R D L G W Q D W I IA P E G Y A A Y Y C E G E C A F P L N S Y M N A TN H A IV Q T L V H
L Y V S F Q D L G W Q D W I IA P K G Y A A N Y C D G E C S F P L N A H M N A TN H A IV Q T L V HL Y V S F Q D L G W Q D W I IA P K
378
382
302
351
363
408
356
356
385
467
424
429
347
396
408
454
402
402
431
513
510 520 530 540
L K N S Q K A S K A C C V P T K L E P IS IL Y L D − K G V V T Y K F K Y E G M A V S E C G C RA S K A C C V P T K Y E G M A V S E C G C R
L K F P T K V G K A C C V P T K L S P IS V L Y K D D M G V P T L K Y H Y E G M S V A E C G C R
R Y Q P H R V P S TC C A P V K T K P L S M L Y V D −N G R V L L D −H H K D M IV E E C G C LV L L D H H K
S V N − S K IP K A C C V P T E L S A IS M L Y L D E N E K V V L K −N Y Q D M V V E G C G C RN Y Q D M V V E G C G C R
S V N − S S IP K A C C V P T E L S A IS M L Y L D E Y D K V V L K −N Y Q E M V V E G C G C R
L M F P D H V P K P C C A P T K L N A IS V L Y F D D S S N V IL K − K Y R N M V V R S C G C H
L M K P N A V P K A C C A P T K L S A T S V L Y Y D S S N N V IL R − K H R N M V V K A C G C HL M K P N A V P K A C C A P T K L S A T S V L YL S A T S V L Y Y D S S N N V IL R K
L M M P D A V P K A C C A P T K L S A T S V L Y Y D S S N N V IL R − K H R N M V V K A C G C H
F IN P E T V P K P C C A P TQ L N A IS V L Y F D D S S N V IL K − K Y R N M V V R A C G C HP C C A P TQ L N A IS V L Y F D D S S N V IL K
L M N P E Y V P K P C C A P T K L N A IS V L Y F D D N S N V IL K − K Y R N M V V R A C G C HY R N M V V R A C G C H
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
BMP−10
GDF−2
NODAL
BMP−2
BMP−4
BMP−5
BMP−8A
BMP−8B
BMP−7
BMP−6
Fig. 3. ...continued.
262 Tandem Mass Spectrometry – Applications and Principles
www.intechopen.com
The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples 5
Fig. 4. Crystal structure of the mature homodimer BMP6. (Saremba et al., 2008) Onemonomer is cartoon rendered with sulfur atoms of cystine knot spacefill rendered. Thestructure with 2R52 accession number was downloaded from Protein Data Bank, andrendered by RasMol.
1.2 Mass spectrometry of proteins
Mass spectrometry (MS) of proteins exploded with the discovery of soft ionization techniquesin late 1980s. Fenn et al. (1989) produced one of the first mass spectra of different proteinsusing electrospray ionization (ESI). They also introduced an algorithm for deconvolution ofmultiple charged envelope in the mass spectra of proteins. Hillenkamp & Karas (1990) did asimilar thing with the matrix assisted laser dissociation ionization (MALDI).Identification of proteins by peptide mass fingerprint (PMF) was introduced by Henzel et al.(1993). Proteins, separated by two dimensional gel electrophoresis (2DE), are in gel protease
digested (usually by trypsin). Peptide masses are then measured by mass spectrometer.The measured peptide mass fingerprint is used for searching the protein sequence databaseby automated computer algorithm. The first large scale analysis using PMF was done byShevchenko et al. (1996). They identified 128 different yeast genes from 150 2D gel spots. Thisscientific approach became proteomics after term proteome coined by Kahn (1995).Protein identification is now done preferentially using tandem mass spectrometry. To avoiderrors and to speed up process, algorithms for the protein database searching using tandemmass spectra of peptides had to be invented. (Eng et al., 1994; Perkins et al., 1999)Except for the identification of proteins, mass spectrometry based quantification becamereality with development of isotope-coded affinity tag (ICAT) strategy. (Gygi et al., 1999)After introduction, there have been devised different stable isotope labeling quantificationstrategies. Ong et al. (2002) developed stable isotope labeling by amino acids in cell culture(SILAC).At last, proteomics community realized the importance of high mass resolving power, highmass accuracy, scanning speed and dynamic range as crucial parameters on which number
and quality of the protein identifications depends. Mann & Kelleher (2008)
263The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples
www.intechopen.com
6 Will-be-set-by-IN-TECH
2. Bone morphogenetic proteins by mass spectrometry
Before 2000 there were only two papers published reporting on separation of the glycoformsof rhBMP-2 by capillary electrophoresis coupled to MS. (Yeung et al., 1997; Yim et al., 1995)From 2000 onward, there is a continuum of scientific research on the BMPs using a massspectrometry. There are two main approaches to the research in the field: (a) isolationand identification of a BMP or related molecule from different biological sources; and (b)proteomic study of a system perturbed using a BMP or related molecule. We have reviewedpapers based on their biological focus.
2.1 Bone and cartilage
BMPs have been discovered and studied first as bone and cartilage growth factors. Afterdevelopment and growth, bones are constantly remodeled to meet their body function.Resorption of the bone is done by osteoclasts and formation by osteoblasts. Therapeuticregeneration and skeletal tissue engineering depends on three elements: extracellular matrix,cells and growth factors. (Reddi, 1998)
Role of BMP-1-3 in bone fracture repair has recently been studied in our group.(Grgurevic et al., 2011) We have shown in vivo enhancement of bone healing by systemicand local administration of BMP-1-3. We used rat fractured femur and critical size defectof rabbit ulnae models and demonstrated a synergistic effect of BMP-1-3 and BMP-7 on boneregeneration. BMP-1-3 stimulates osteoblast differentiation in vitro. By combining isolationof growth factors with proteomic global approach we have identified potential biomarkersof acute bone fracture from plasma of 25 patients. (Grgurevic et al., 2007) To overcomeinherent limitation of proteomics to cope with plasma protein dynamic range of more than10 orders of magnitude, we have devised a growth factors enrichment strategy. Membersof TGF- protein superfamily have characteristic heparin binding domain as part of theirstructure, and can be affinity enriched using heparin chromatography. We enriched growthfactors from 80 mL of pulled plasma, and than separeted them on minigel electrophoresis.To overcome loading capacity of analytical gels, proteins were loaded into consecutive wells,and afterwards combined in 12 fractions by electrophoretic mobility. After in-gel digestion,peptides were separated and measured by on-line nano LC coupled to Orbitrap workingin data dependent scanning mode. Top five MS signals were isolated and fragmented by
CID in linear IT. Global proteomic approach allowed us to identify 213 proteins, of whichwe have singled out 12 bone and cartilage related proteins. Four of them have never beforebeen found in the circulation: Transforming growth factor -induced protein ig-h3 ( ig-h3),cartilage acidic protein 1 (CRTAC1), procollagen C proteinase enhancer protein (PCPE-1) andTGF- receptor type 3 (TGF- -R-3). Nakasaki et al. (2008) have identified insulin-like growthfactor I(IGF-I) as potent chemotactic factor for osteoblasts and showed IGF-I involvementin fracture healing. They used five step sequential chromatography to purify IGF-I from18 L of MC3T3-E1 (mouse osteoblast-like cell line) serum free conditioned media (CM). Afterprecipitation of CM with 80% saturated ammonium sulphate, they used gelatine-, Blue-,heparin-affinity chromatography, hydroxyapatite chromatography and gel filtration to purifyIGF-I more then 200 fold. IGF-I was separated by silver stained SDS-PAGE, in gel digested,and measured by micro LC coupled to 3D IT working in data dependant mode.Kim et al. (2009a) have studied transdifferentiation of murine premyoblast C2C12 cell lineinduced by BMP-2. They invented the Two-Stage Double-Technique Hybrid (TSDTH)proteomic strategy, for the analysis of early phosphoproteome and late proteome changes.
264 Tandem Mass Spectrometry – Applications and Principles
www.intechopen.com
The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples 7
Authors have enriched more then 150 g of phosphoproteins from 2 mg of the total proteincell lysate using commercial kit. Using a phosphoprotein enrichment, as opposed to aphosphopeptide enrichemnt, one should get a better sequence coverage of the individualphosphorylated proteins. Phosphoproteins were separated by SDS-PAGE, in gel digested,and analysed by micro LC coupled to linear IT. They measured MS3 fragmentationspectra of phosphopeptides showing dominant neutral loss of phospho moiety (minus98 Th/49 Th/32.7 Th for singly, doubly or triply charged species respectively) using datadependant mode. For the proteome quantification, authors metabolically labelled all cellproteins using SILAC approach. After combining samples, they separated proteins usingSDS-PAGE, in gel digested them, and analysed them by micro LC coupled to LTQ-FT workingin data dependent mode. Top five signals from high resolution survey scan were measuredindividually using single ion monitoring (SIM) scan in FT-ICR analyser, and then CIDfragmented in linear IT. From 1321 phosphoproteins identified and 433 proteins quantifiedauthors selected 374 BMP-2 specific phosphoproteins and 54 differentially expressed proteins.By pathway enrichment analysis authors found IGF and calcium signaling pathways as well
as TGF- /BMP signaling proteins to be potentially involved in the early and long-term actionsof BMP-2.At present, BMP-2 and BMP-7 are the only BMPs commercially used for regenerativepurposes. We have identified lysine 60 of BMP-6 as amino acid crucial for BMP-6 lowersusceptibility to noggin inhibition in comparison to BMP-7. (Song et al., 2010) This isimportant because of the present therapeutic use of BMP-7 in large doses. In BMP-6, lysine 60forms intramolecular hydrogen bonds with asparagine 65 connecting finger 1 and 2 in thatway that it increases overall rigidity of the molecule.Osteoporosis is one of the most prevalent bone disease. (Raisz, 2005) We have studiedeffects of systemically administered BMP-6 to osteoporotic rats. (Simic et al., 2006) Wecould not demonstrate the presence of BMPs in bone extract of ovariectomized rats.We next demonstrated that systemically administered recombinant human mature BMP-6accumulates in the skeleton. BMP-6, systemically applied, restores the bone inductivecapacity, microarchitecture, and quality of the skeleton in osteoporotic rats. Next, usinggene expression profiling, we found that BMP-6 exerts its osteoinductive effect at leastin part through the IGF-I and epidermal growth factor (EGF) pathways. (Grasser et al.,
2007) Hong et al. (2010) have studied impairment of osteoblasts differentiation in contextof the glucocorticoid-induced osteoporosis. They treated MC3T3-E1 cells with high dose ofdexamethasone, which inhibited cell differentiation and proliferation and induced apoptosis.Authors used SILAC labelling with heavy/light lysine, SDS-PAGE protein separation andnano LC coupled to LTQ-Orbitrap proteomic approach. They found upregulation of tubulins(TUBA-1A, TUBB-2B, and TUBB-5), Ras GTPase-activating-like protein 1 (IQGAP1), S100proteins (S100-A11, S100-A6, S100-A4, and S100-A10), myosins (MYH-9 and MYH-11), andapoptosis and stress proteins (BAX), and downregulation of ATP synthases (ATP5O, ATP5H,ATP5A1, and ATP5F1), G3BP-1, and Ras-related proteins (RAB-1A, RAB-2A, and RAB-7).Hong et al. (2010a) have studied early osteoblast differentiation. They induced differentiationof mouse osteoprogenitor MC3T3-E1 cells by rhBMP-2 and have studied cells in an earlydifferentiation stage critical for transformation of premature osteoblasts to mature osteoblasts.At that stage osteoblasts express ALP but do not form mineralized nodules yet. By label-freequantitative proteomic approach they identified numerous differentially expressed proteinsimportant for actin skeleton regulation and/or focal adhesion. They used SDS-PAGE proteins
265The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples
www.intechopen.com
8 Will-be-set-by-IN-TECH
separation, and nano LC coupled to LTQ-Orbitrap peptide analysis. By western blot they haveconfirmed upregulation of IQGAP1, isoform 1 of gelsolin (GSN), moesin, radixin, and cofilin 1(CFL-1), and upregulation of focal adhesion proteins FLN-A, LAMA1, LAMA5, COL1A1,COL3A1, COL4A6, and COL5A2, as well as the downregulation of COL4A1, COL4A2, andCOL4A4.Park et al. (2009) have studied heparin-binding growth factor 2 (HBGF-2 ) effect onosteoblasts. Authors used 2DE/MALDI-TOF proteomic approach. They identifiedasparaginyl-tRNA synthetase (NARS), eukaryotic peptide chain release factor subunit 1(ETF1), GDP-forming succinyl-CoA synthetase (SUCLG2), heat shock protein 84 (HSP 84),sorting nexin 9 (SNX9) and neutral -glucosidase AB (GANAB) to be upregulated, andtropomyosin 2 to be downregulated. NARS, member of aminoacyl-tRNA synthetases (AARS),was upregulated more then 900 fold. NARS upregulation increased the cell proliferation.NARS downregulation suppressed cell proliferation and induced cell apoptosis. Alsodownregulation of NARS increased serum deprivation induced apoptosis. Reduction ofNARS also reduced p-Akt activity and increased caspase-3. Authors shown that HBGF-2
induced NARS promotes osteoblast survival through PI3K/Akt pathway.Kodaira et al. (2006) have purified BMP-like factor from fetal bovine serum (FBS), whichthey found to both inhibits myogenesis and stimulates differentiation of osteoblasts. Theystarted with 5 L of FBS, which they separated by heparin, strong anion exchange (SAX),heparin again, strong cation exchange (SCX) and reverse phase chromatography. UsingLC-MS/MS authors identified this factor as BMP4, and found it to be in over 100 kDa complexin circulation. Behnam et al. (2006) identified dermatopontin (DPT) as the most prominentBMP-2 co-purified demineralized bone matrix protein, using alkaline urea extraction of BM,separation of insoluble fraction by hydroxyapatite chromatography, SDS-PAGE of BMP activefraction and MALDI-TOF analysis. Kubota et al. (2002) have studied signal transduction fromosteoclasts to osteoblasts. They have isolated and identified osteoblastogenesis inhibitoryfactor (OBIF) from RANKL treated RAW264.7 cell line conditioned medium. This OBIFinhibited osteoblastogenesis of MC3T3-E1 cell line, induced by BMP-4. After three stepchromatography (heparin affinity, anion exchange and reverse phase chromatography) from1.8 L of conditioned medium, they have managed to identify OBIF as platelet-derived growthfactor BB (PDGF BB) homo-dimer using nano LC coupled to LCQ ion trap, working in data
dependant mode..
2.1.1 Chondrogenesis
Ji et al. (2010) have studied mesenchymal stem cells chondrogenesis. They inducedchondrogenic differentiation of C3H10T1/2 cells, murine embryonic mesenchymal cell line,by treatment with BMP-2. They validated chondrogenesis by following glycosaminoglycanand collagen type II. By isobaric tags for relative and absolute quantitation (iTRAQ) labelingand 2D nano LC-MS/MS (QSTAR XL) analysis they identified 100 differentially expressedproteins out of 1753 identified and quantified proteins. 83 proteins were downregulated,and 17 upregulated. This is in concordance with “stem state” concept, which assumes widerset of proteins expressed in cells which are less differentiated. Collagen types II and XI areupregulated, as are PAPSS 2 and LOX, enzymes involved in posttraslational modification ofchondrocytes extracellular matrix components. Most enriched category of downregulatedproteins is energy metabolism. Chondrocytes produce ATPs by anaerobic glycolysis, becausecartilage is avascular and hypoxic. IGF-I was upregulated and was shown to exhibit additive
266 Tandem Mass Spectrometry – Applications and Principles
www.intechopen.com
The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples 9
effect on chondrogenesis with BMP-2. Fibulin-5, an ECM protein, was upregulated. BTF3L4,general transcription factor, was upregulated. Kim et al. (2010) have studied chondrogenesisof adipose tissue-derived stem cells (ASCs). They identified 756 proteins using nano LCcoupled to LCQ MS/MS approach. From 33 chondrogenic factors or proteins identifiedauthors especially mentioned type 2 collagen, biglycan, IGF-binding protein and TGF- 1.
2.2 Stem cells
One of the approaches in the regenerative medicine is the use of stem cells as cell therapies.(Keller, 2005; Murry & Keller, 2008; Wobus & Boheler, 2005) Their self renewal capability,the unlimited potential for differentiation, and signals that control differentiation fate areunder broad scientific scrutiny. We have reviewed the role of BMP-6 in mesenchymal stemcell differentiation. (Vukicevic & Grgurevic, 2009) BMP-6 roles have been reviewed in boneremodeling, bone to pancreas coupling and kidney development.Lee et al. (2010) have studied BMP-2 induced differentiation of bone marrow stem cells(BMSC). They identified and quantified 449 proteins using SILAC LC-MS/MS approach.Proteins were separated by SDS-PAGE and in gel digested. Peptides were separated by
LC and analysed by LTQ-FT, working in the data dependant mode. Top five signals fromthe survey scan were measured in the FT analyser using SIM, and CID fragmented in thelinear IT. 12 proteins were upregulated, 7 proteins were downregulated, and 19 proteinswere only detected in BMP-2 induced cells. Authors singled out -catenin (identified onlyin BMP-2 induced differentiated cells with 4 peptides). Wnt/ -catenin pathway is known tobe important in osteoblast differentiation. They ruled out Smad and ERK BMP pathways on
-catenin upregulation. They identified PI3K pathway as crucial for BMP-2 induced BMSCdifferentiation. Willert et al. (2003) have for the first time isolated Wnt3a in an active form.They have expressed Wnt3a in mouse L cells, purified it from 2 L of conditioned medium bythree step chromatography (Blue sepharose, gel filtration and heparin cation exchange) in thepresence of CHAPS, due to hydrophobic nature of the Wnt protein. They have pinpointedhydrophobicity to lipid modification, and have identified cysteine 77 as place of palmitation,by MudPIT.Hoof et al. (2009) studied phosphorylation dynamics during BMP4 induced differentiationof hESCs. They used SILAC labeling and phosphopeptide enrichment by SCX-TiO2chromatography. High resolution Orbitrap, working in the data dependant top two mode,
was used for the measurement of peptides in four time points (0, 30, 60, 240 min). Authorsidentified 5222 proteins, of which 1399 were phosphorylated on 3067 sites (2431 serines, 582threonines, and 54 tyrosines). Half of the quantified phosphopeptides are regulated withinthe first hour of BMP-4 initiated differentiation. 586 identified proteins are regulated by thecore transcriptional network. By a GO analysis prominent protein groups are associatedwith the epigenetic modification, transcription and translation. Authors found increasedphosphorylation of SMADs, PI3K/AKT pathway activation and transient activation of JNKs.Regulators of pluripotency are also altered, but SOX2 did not changed its phosphorylationstatus. By analysis of the predicted kinases responsible for measured phosphorylation,authors found that CDK1/2 has central role.Yocum et al. (2008) have identified and verified several potential markers of noggin-inducedneural and BMP-4-induced epidermal ectoderm differentiation of hESCs. They developedhESCs cell culture system (on gelatin-coated dishes) free of mouse embryonic fibroblasts(MEF) feeder layer or conditioned media. In this way targeted proteome is not contaminated
267The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples
www.intechopen.com
10 Will-be-set-by-IN-TECH
by proteins from MEFs and noggin/BMP4 effect on hESCs is not influenced by possibleMEFs response. They used 2D LC/MALDI-TOF/TOF (ABI 4800 TOF/TOF) for globalanalysis and MRM on 4000 Q Trap for verification and targeted analysis. Beside verificationof tubulin -III and cytokeratin-8, previously known markers for neuronal and epithelialdifferentiation respectively, they proposed nuclear autoantigenic sperm protein (NASP) asmarker for pluripotency and dihydropyrimidinase-related protein (DRP) 2 and 4 as markersfor the early neuronal differentiation.Nunomura et al. (2005) have identified 200 membrane proteins from mouse embryonic stemcells using biotin based cell surface labeling, biotin-avidin affinity peptide purificationand 2D LC-MS/MS analysis on Q-Tof 2. Among 82 proteins involved in different cellsignaling pathways, they identified leukemia inhibitory factor receptor (LIF-R), interleukin-6receptor subunit (IL-6R ), ciliary neurotrophic factor receptor (CNTFR- ), BMPR-1a andintegrin 6 1.Prowse et al. (2005) identified 102 proteins secreted by human neonatal fibroblasts, whichare used for maintenance of undifferentiated growth of human embryonic stem cells, using
2D LC-MS and 2DE/MALDI-TOF. Among others they have identified proteins involvedin cell adhesion, cell proliferation and inhibition of cell proliferation, Wnt signaling andinhibition of BMPs.Kurisaki et al. (2005) have studied effects of the removal of leukemia inhibitory factor (LIF)from mouse embryonic stem cells. LIF maintains pluripotency of mouse ESCs, by activatingJAK/STAT3 pathway. Only in cooperation with BMPs, can LIF inhibit differentiation of mouseESCs. BMPs activate expression of Id genes and suppress neuronal differentiation. Authorsidentified more then 100 proteins by DIGE and MALDI-TOF analysis on AXIMA-CFR Plusand/or 4700 Proteomics Analyzer.
2.3 Cancer
BMPs, as part of the TGF- protein superfamily, are involved in the cancerpatophysiology. (Massague, 2008) Klose et al. (2011) have shown BMP-7 induced cellcycle arrest at G1/S checkpoint of human glioma-derived Gli36 EGFR-LITG cells. Kim et al.(2009) have studied PRL-3-mediated metastasis using B16 and B16F10 mouse melanomacell lines. Using 2D DIGE and MS they identified the heat shock protein 70, fascin-1,septin-6, ATP synthase beta subunit, and bone morphogenetic protein receptor type IB,
as proteins that differ in cancer cells with low and high metastatic potential. We showedthe inhibitory role of BMP-7 to bone metastases of breast cancer (Buijs et al., 2007) andprostate cancer (Buijs et al., 2007a). The cancer metastasis can be triggered by TGF-stimulating epithelial-to-mesenchymal transition. Recombinant BMP-7 is inhibiting cancerbone metastases growth, so we proposed it as novel therapy for bone metastases. Rivera et al.(2007) have identified 43 differentially expressed proteins in melanoma cell line with breastcancer metastasis-suppressor 1 (BRMS1) gene silenced or over-expressed compared to wildtype. They used 2D-DIGE for relative quantification and MALDI-TOF/TOF (ABI 4800TOF/TOF Analyzer) for protein identification from preparative 2D gel. Among others theyidentified and confirmed BMPR-II. van Gils et al. (2005) reviewed serum and urine markersin European prostate cancer P-Mark project. BMP-6 was considered as bone metastasisprognostic serum marker, but later dismissed due to technical challenges in BMP-6 serumdetection. Cheung et al. (2004) have identified 24 kDa SELDI-TOF signal specific to earlyprostate carcinogenesis as dimeric form of mature GDF-15. By laser capture micro-dissection
268 Tandem Mass Spectrometry – Applications and Principles
www.intechopen.com
The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples 11
(LCM) they have isolated normal, early cancer (Gleason grade 2 to 4) and high-grade prostaticintraepithelial neoplasia (hPIN) epithelial cells from 22 patients. For SELDI-TOF analysis,authors used a copper IMAC chemistry, and proteins measured by Ciphergen Protein BiologySystem II spectrometer (Ciphergen Biosystems, Inc.). For the protein identification, authorsfirst separated proteins by SDS-PAGE. 24 kDa band was analysed by oMALDI Q-TOF (ABIQ-Star).
2.4 Kidney
We have previously reviewed the role of BMPs on the development and homeostasis ofkidneys. (Simic & Vukicevic, 2005) BMPs have been connected to kidney biology already in1990s. The BMPs role in kidney development has been discovered by early localization studiesusing immunohistochemistry (Vukicevic et al., 1994a), autoradiography (Vukicevic et al.,1990) and in situ hybridization (Helder et al., 1995; Vukicevic et al., 1994). We have shown thatBMP-7 is crucial for metanephric mesenchyme differentiation during kidney development.(Vukicevic et al., 1996)BMP-7 is effective in treatment of acute renal failure, as we have shown in a
ishemia/reperfusion rat model. (Vukicevic et al., 1998) Wang & Hirschberg (2011) haveidentified Y-box protein-1 (YB-1) as BMP-7 transcriptional activator in context of chronickidney disease (CKD) using LC-MS/MS. They used promotor region of BMP7 gene to fish outfactors from MDCK nuclear fraction. Proteins were separated by SDS-PAGE, and analysedby nano LC coupled to LTQ-Orbitrap XL. We have identified BMP-6, GDF-15 and BMP-1-3from plasma of healthy volunteers and patients with CKD. (Grgurevic et al., 2011a) Weshowed an increased renal fibrosis in rats with CKD after systemic administration of BMP-1-3.Administration of anti BMP-1-3 antibody reduced the fibrosis.
2.5 Iron
Iron content is tightly controlled by individual cell and also systemically by hole organism.(Hentze et al., 2004; 2010) We found that BMP-6 is an endogenous regulator of ironmetabolism in vivo. (Andriopoulos et al., 2009) Bmp6 knockout mouse has reduced hepcidinexpression and tissue iron overload, which resembles hemochromatosis. Hepcidin hasa central role in maintaining iron body levels. Recombinant BMP6, when administeredto mouse with hemochromatosis reduced the serum iron in a dose-dependent manner.Next, we found that BMP-6 treatment reduces hemochromatosis in Hfe knockout mouse.
(Corradini et al., 2010) We also showed BMP-6 effect on TMPRSS6 expression, which is anegative regulator of hepcidin. (Meynard et al., 2011)Kartikasari et al. (2008) used SELDI-TOF MS to detect and quantify hepcidin-25, 25 residueslong hepcidin isoform which regulates the iron homeostasis. Authors used cation exchangechip for protein binding, and Ciphergen Protein Biology System IIc TOF mass spectrometerfor the measurements. They found synergistic upregulation of hepcidin-25 by BMP-2/9 andIL-6, suggesting a crosstalk between iron and inflammatory pathways.
2.6 Other
BMP-15 is oocyte secreted growth factor important for female fertility. (Elvin et al., 2000)Saito et al. (2008) have characterized rhBMP-15 expressed in human embryonic kidney 293cells by MS. Authors used MALDI-TOF (Reflex 3, Bruker) for the protein molecular weightmeasurement and micro LC coupled to LTQ-Orbitrap for the CID fragmentation and the
269The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples
www.intechopen.com
12 Will-be-set-by-IN-TECH
neutral loss measurements. They found N-terminal amino acid to be pyroglutamic acid andC-terminal end to be truncated. 16 kDa BMP-15 form is phosphorylated on serine 6 and17 kDa BMP-15 form is O-glycosilated on threonine 10. Tibaldi et al. (2010) have identifiedserine 6 from mature BMP-15 and BMP-9 to be phosphorylated by Golgi apparatus caseinkinase (G-CK). Phosphorylation sites were identified using phosphopeptide enrichment andnano LC coupled to LCQ XL, or MALDI-TOF/TOF (ABI 4800 Plus) analysis.Li et al. (2007) have studied ubiquitination of Smad1 mediated by carboxyl terminus ofHsc70-interacting protein (CHIP). They have confirmed N-termus mono-ubiquitination ofSmad1 by MALDI-TOF analysis of in vitro ubiquinated Smad1.Pulmonary arterial hypertension (PAH) was reviewed by Rubin (1997) and Rabinovitch(2008). Abdul-Salam et al. (2010) found 25 differentially expressed out of more than 300identified proteins by SDS-PAGE and LC-MS/MS from lung tissue of 8 patients and 8control subjects. They found for the first time increased expression of chloride intracellularchannel 4 (CLIC4), receptor for advanced glycation end products, and periostin. Meyrick et al.(2008) found 16 differentially expressed proteins in familial pulmonary arterial hypertension
(FPAH) patients compared to obligate carrier from the same family with known BMPR-2mutation. They used 2D-DIGE/MALDI-TOF(/TOF) of EBV-transformed B lymphocytes.They connected adapter protein growth factor receptor bound protein (GRB2) to signaltransduction of BMPR-2 receptor.Pappano et al. (2003) have identified in vivo substrates of BMP-1 and mammalian Tolloid-likemetalloproteinases (mTLL) using proteomics. They compared in vivo procollagenC-proteinase (pCP) activity of wild type vs Bmp1 Tll doubly homozygous null mice. Usingnano ESI-QTof sequencing, they have identified four 2DE spots (absent in Bmp1–/– Tll–/–
mouse embryo fibroblasts, MEF, conditioned media) as C-propeptides of the pro 1 chain oftype I procollagen, of the pro 1 chain of type III procollagen, of the pro 2 chain of type IIIprocollagen and for the first time proline- and arginine-rich protein (PARP) subdomain of theN-terminal globular sequences of the pro 1 chain of type XI collagen.The low resolution structure of procollagen C-proteinase enhancer 1 (PCPE-1), an extracellularmatrix glycoprotein that can stimulate the pCP action of tolloid metalloproteinases, wasdetermined by Bernocco et al. (2003). Using MALDI-TOF they have determined MW ofPCPE-1 to be 48628 Da. Wajih et al. (2004) have studied intracellular processing and transport
of the matrix -carboxyglutamic acid protein (MGP) in human vascular smooth muscle cells(VSMCs) infected with adenovirus carrying the MGP construct. MGP is an inhibitor of arterialwall and cartilage calcification through the binding of BMP-2. They have identified bovinefetuin instead of MGP using SDS-PAGE followed by nano LC coupled to LCQ Deca XLion trap MS. Using glutathion-S-transferase (GST) pull-down followed by 2DE/MALDI-TOFanalysis, Hassel et al. (2004) identified 33 proteins interacting with BMPRII. Wermter et al.(2007) studied the substrate selectivity of BMP-1 using the full-length vs. isolated proteolyticdomain of BMP-1. They managed to over-express BMP-1 catalytic domain in E. coli andto refold it properly. By MALDI-TOF analysis of reduced vs. unreduced tryptic peptidesthey confirmed the proper formation of three disulphide bridges (C65-C85, C43-C199 andC63-C66). Number of ligands that are binding to activin type II receptor (ActRII) and ActRIIBfrom human and mouse sera have been identified using affinity purification, SDS-PAGE andnano LC coupled to linear IT (LTQ). (Souza et al., 2008) They confirmed that in addition tomyostatin, BMP-11 and activins-A, -B and -AB could regulate the muscle growth by inhibitingmyblast-to-myotube differentiation. Meleady et al. (2008) have compared Chinese hamster
270 Tandem Mass Spectrometry – Applications and Principles
www.intechopen.com
The Use of Mass Spectrometry in Characterization of Bone Morphogenetic Proteins from Biological Samples 13
ovary (CHO) cells expressing rhBMP-2 to cell co-expressing soluble exogenous paired basicamino acid cleaving enzyme (PACEsol), which improves post-translational processing of themature rhBMP-2. They used 2D-DIGE/MALDI-TOF and found 60 differentially expressedproteins.
3. Conclusion
Growth factors MS based characterization from biofluids is almost exclusively done by CIDon plethora of different tandem instruments. Very low levels of growth factors in circulation islimiting their MS based identification due to huge dynamic range of plasma/serum proteins.Different biochemical purification strategies are used to enrich individual growth factorsenough to be able to analyse it by MS. Most of them use heparin affinity chromatography asone purification step. We have successfully identified number of growth factors from biofluidsusing heparin based enrichment, followed by the SDS-PAGE protein separation and peptideanalysis on nano LC coupled to LTQ-Orbitrap.
4. Future prospects
Disparity between liters of starting material used in the isolation and identification studies ofindividual growth factors from biological fluids, and an unmet need to use small amounts ofbiological samples for high throughput clinically relevant studies, is ending by developmentof growth factors enrichment strategies and of course by development of new and better massspectrometers, and/or new proteomic strategies.In the future we can expect more and more proteomic studies with BMPs and other growthfactors to be identified, quantified and/or characterized from different clinically relevantsamples. This will help to better understand particular diseases, discover new biomarkersand to develop new therapeutic strategies.
5. Abrreviations
2DE Two dimensional gel electrophoresis
ig-h3 Transforming growth factor- -induced protein ig-h3 ( ig-h3)
InTech ChinaUnit 405, Office Block, Hotel Equatorial Shanghai No.65, Yan An Road (West), Shanghai, 200040, China
Phone: +86-21-62489820 Fax: +86-21-62489821
Tandem Mass Spectrometry - Applications and Principles presents comprehensive coverage of theory,instrumentation and major applications of tandem mass spectrometry. The areas covered range from theanalysis of drug metabolites, proteins and complex lipids to clinical diagnosis. This book serves multiple groupsof audiences; professional (academic and industry), graduate students and general readers interested in theuse of modern mass spectrometry in solving critical questions of chemical and biological sciences.
How to referenceIn order to correctly reference this scholarly work, feel free to copy and paste the following:
Genadij Razdorov and Slobodan Vukicevic (2012). The Use of Mass Spectrometry in Characterization of BoneMorphogenetic Proteins from Biological Samples, Tandem Mass Spectrometry - Applications and Principles, DrJeevan Prasain (Ed.), ISBN: 978-953-51-0141-3, InTech, Available from:http://www.intechopen.com/books/tandem-mass-spectrometry-applications-and-principles/the-use-of-mass-spectrometry-in-characterization-of-bone-morphogenetic-proteins-from-biological-samp